Capricor Therapeutics, Inc.

DB:4LN2 Stock Report

Market Cap: €813.0m

Capricor Therapeutics, Inc. Company Information

Capricor Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Capricor Therapeutics, Inc.
  • Ticker: 4LN2
  • Exchange: DB
  • Founded: 2005
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$846.650m
  • Listing Market Cap: US$813.038m
  • Shares Outstanding: 45.47m
  • Website: https://www.capricor.com

Number of Employees

Location

  • Capricor Therapeutics, Inc.
  • 10865 Road to the Cure
  • Suite 150
  • San Diego
  • California
  • 92121
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CAPRNasdaqCM (Nasdaq Capital Market)YesNew Common StockUSUSDNov 2013
4LN2DB (Deutsche Boerse AG)YesNew Common StockDEEURNov 2013

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/24 01:22
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.